Home monitoring to stop sepsis from getting worse
Part of Infections clinical trials.
This study tests a home monitoring system for people who come to the ER or their doctor with a serious infection that could turn into sepsis. The goal is to see if watching you at home can help catch worsening signs early and prevent hospitalization.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can make your own decisions about joining a study.
- You have signs of a serious infection (like a high fever or feeling very ill) that could turn into sepsis.
- You are not so sick that you need to stay in the hospital right now (your doctor would decide this).
- You do not have confusion, memory problems, or dementia that would make it hard to follow instructions.
- You are not on chemotherapy or strong immune-suppressing medications, and you do not have HIV or AIDS.
- You do not have serious heart or lung problems (like advanced heart failure, COPD, or a recent heart attack).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study looks at whether automatically flagging a sepsis risk score in the electronic health record and having a care team respond with structured steps helps treat sepsis earlier. If you qualify, everything is done through your usual care — you won't have extra visits or be contacted by the research team.
This study tests a wearable sensor system in intensive care patients to see if it can predict sepsis early. Sepsis is a life-threatening reaction to infection, and catching it sooner could lead to faster treatment.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This study collects information from patients with sepsis (a serious infection that affects the whole body) who come to the emergency department. The goal is to better understand and improve care for people with this condition.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.